Bristol-Myers Squibb (NYSE:BMY) reported positive top-line Phase 2 results for Reblozyl in alpha-thalassemia related anemia, ...
Hosted on MSN
Big Pharma Layoff Wave Extends Into Next Year: UNH, Merck, BMS, Novartis File New WARN Notices
・Layoff filings show UnitedHealth’s Optum units planning the largest set of early-2026 job reductions among major healthcare employers. ・Merck, Bristol Myers Squibb, and Novartis are pushing through ...
Bristol-Myers Squibb (NYSE:BMY – Free Report) had its target price reduced by Jefferies Financial Group from $70.00 to $68.00 in a research report sent to investors on Wednesday morning,Benzinga ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results